A need of the hour: pharmacovigilance in healthcare setting – nothing less than safety

Journal: International Journal of Current Research in Physiology and Pharmacology

Article type: Research Article

Published: 2024-02-28

Volume: 7; Issue: 4S3; Pages: 19-24

ISSN: 2456-3891

Article URL: https://journals.sumathipublications.com/article/article-1782846120146-802528805

PDF: https://journals.sumathipublications.com/article/article-1782846120146-802528805.pdf

JATS XML: https://journals.sumathipublications.com/article/article-1782846120146-802528805.xml

Authors

  1. Preeti Shanbhag
    Pg scholar, Srinivas college of Pharmacy, Valachil, Mangalore.
  2. Satish S
    Professor, Department of Pharmacy Practice, Srinivas College of Pharmacy, Valachil, Post Farangipete, Mangalore, Karnataka, India-574143.
  3. Ramdas Bhat
    Assistant Professor, Department of Pharmacology, Srinivas College of Pharmacy, Valachil, Post Farangipete, Mangalore, Karnataka, India-574143.
  4. A R Shabaraya
    Principal and Head of the Department of Pharmaceutics, Srinivas College of Pharmacy, Valachil, Post Farangipete, Mangalore, Karnataka, India

Abstract

Introduction : Pharmacovigilance (PV) is crucial to identify, managing, and reporting adverse drug reactions (ADRs) in the healthcare sector. Young healthcare professionals (HCPs) play an essential role in the PV system. Objective : This study aimed to assess awareness, understand the causes of underreporting, and find solutions to encourage ADR reporting among young HCPs. Methods : This prevalidated, questionnaire-based, cross-sectional study aimed to evaluate the knowledge, attitude, perception, and strategies to improve PV reporting among 152 young HCP interns at a teaching hospital in India. The study was conducted in January 2023 and approved by the ethics committee. The responses were analysed using a Microsoft Excel worksheet . Results In a study of 152 interns, 97.3% agreed that pharmacovigilance (PV) may assist patients, but only 56% had experienced adverse drug reactions (ADRs) in practise. Only 40.5% chose email reporting, and 65.8% did not have a nearby ADR Monitoring Centre (AMC). More over half (53%) thought ADRs should only be reported to an AMC. Training sessions were underutilised, with only 28.6% attending PVPI training. The difficulty in identifying the causal substance, as well as a lack of incentives, were important reasons for underreporting. Continuing medical education/workshops were mentioned by 96% of young HCPs as a way to encourage reporting. Conclusion: According to the study, while young HCPs are aware of PV, there is a need for more training and incentives to enhance ADR reporting. Encouragement of National Pharmacovigilance Week and the availability of neighbouring AMCs could further aid raise PV awareness. Keywords: Adverse drug reactions (ADR), PVPI, AMC, CME

Keywords

Key words: Adverse drug reactions (ADR), PVPI, AMC, CME

Full Text

HTML full text is not available. Refer to the PDF galley.